Tag: ALL
-
![ERYTECH Pharma (ERYP.Q) has a GRASPA® on ALL, shares up +70%]()
ERYTECH Pharma (ERYP.Q) has a GRASPA® on ALL, shares up +70%
A Need for Alternatives $54.898M Market Capitalization ERYTECH Pharma (ERYP.Q) announced today that the Company has sold its US manufacturing facility to Catalent, a leading contract development and manufacturing organization (CDMO) in advanced therapies. Under the terms of the agreement, Catalent has agreed to purchase ERYTECH’s US facility for a total consideration of $44.5 million. That’s…
-
Plus Products (PLUS.C) just parachuted right into my world
Heimark has a track record of rigorous market research prior to launching products. This research-based approach has reaped dividends in market penetration and revenue growth.
-
![Plus Products (PLUS.C): good deeds, good products, good numbers]()
Plus Products (PLUS.C): good deeds, good products, good numbers
“This will be the third year we have had the opportunity to partner with a local organization during pride month,” stated Mr. Heimark. “Last year we sold over 60,000 units and are looking forward to giving that record a run for its money this year.”
-
Plus Products (PLUS.C) partners with a Legend
“John Legend is getting into the cannabis business with a new brand partnership with San Mateo-based Plus Products” stated The Hollywood Reporter on September 17, 2019, “As an investor, the EGOT winner will advocate for the company’s new hemp CBD products, which launch nationwide on Tuesday. Being an “EGOT winner” is a reminder that God…
